Closed · RFA-DD-14-001 · CFDA 93.315 · Discretionary

Surveillance and Research of Muscular Dystrophies and Neuromuscular Disorders

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

Varies
Award range
Closed
Status
March 12, 2014
Close date
10
Expected awards

The verdict

Surveillance and Research of Muscular Dystrophies and Neuromuscular Disorders is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered Varies by applicant across 10 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

Varies
award range
Closed
application status
10
expected awards
93.315
CFDA program

Archived opportunity record

Surveillance and Research of Muscular Dystrop… is closed (last close March 12, 2014). Check the agency catalog for replacement NOFOs. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed March 12, 2014

Posted Feb 26 Closes Mar 12

Est. Total Funding

$15,500,000

Expected Awards

10

Instrument

Grant

Description

• Purpose. Using methods based on those from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet), this funding opportunity announcement (FOA) will support: 1. Conducting population-based surveillance, longitudinal follow-up, and public health research for muscular dystrophies and neuromuscular disorder(s): 1) to develop estimates for prevalence, survival, healthcare service use and costs, disparities in access to care (by proximity to source of care, race/ethnicity, and SES), and 2) to determine associations between specific clinical treatments and specific outcomes for specific types of MD and neuromuscular disorders, and 3) to support public health and clinical practice for prevention of morbidities and their progression among persons with muscular dystrophy and neuromuscular disorders 2. Expanding the number of surveillance site(s) to increase the demographic, racial, and ethnic diversity in the current MD surveillance system 3. Sharing data with stakeholders seeking to improve health and access to care of people living with these conditions 4. Evaluating, modifying, and documenting the methodology and infrastructure of the surveillance system 5. Conducting pilot studies that investigate specific MD knowledge gaps and sharing results with participants and stakeholders This FOA has four components to achieve the purpose of the program. Components A and B consist of the core activities. Component A - core (existing MD surveillance and research programs) consists of using methods based on those from MD STARnet and lessons learned from previous MD surveillance systems to conduct surveillance and longitudinal follow-up for muscular dystrophies and neuromuscular disorder(s); maintaining current and building new key partnerships; analyzing data to produce findings useful for public health practice; disseminating results to stakeholders using data collected from current and previous MD surveillance programs; and evaluating, modifying, and documenting the surveillance methods and infrastructure. Component B - core (new MD surveillance and research programs) consists of building a system using methods based on those from MD STARnet to conduct surveillance and longitudinal follow-up for muscular dystrophies and neuromuscular disorder(s) in a population with a large minority group (i.e. African Americans, Hispanics, Asians); building new key partnerships; analyzing data to produce findings useful for public health practice; disseminating data to stakeholders; and evaluating, modifying, and documenting the surveillance methods and infrastructure. Component C consists of the data coordinating center (DCC) and abstractor training and quality assurance/control that support the core activities. Component D consists of additional muscular dystrophy research studies in which applicants design a study to address a knowledge gap in MD and share data with study participants and MD stakeholders. (Note: The methodology for component D studies will not be known until applications have been submitted. Studies that collect data on 10 or more people are required to have OMB approval unless one of several exemptions apply. Data will not be collected without the Office of Management and Budget’s (OMB) approval.)

Catch-all / unrestricted eligibility mark · RFA-DD-14-001

Grants.gov marks Surveillance and Research of Muscular Dystrop… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention - ERA book (299 peers, 47% of 640).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700 E-mail: pgotim@cdc.gov

What to do next

Surveillance and Research of Muscular Dystrop… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.315 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants